You may have read headlines saying “Aspergillosis can spread to the brain and is one of the world’s deadliest fungal infections.”
That sounds frightening — but here’s what’s really known.
💬 The truth behind the headline
It’s true that the Aspergillus fungus can affect the brain, but this is very rare and happens only in people who are severely unwell or have very weak immune systems (for example, after chemotherapy, bone-marrow transplant, or very high-dose steroids for long peroids).
For most people with aspergillosis — whether allergic (ABPA) or chronic (CPA) — the infection stays in the lungs or sinuses. These forms do not usually spread to other parts of the body.
⚙️ How brain infection can happen
When it does occur, the fungus can reach the brain in two ways:
-
Through the bloodstream — from an invasive infection in the lungs.
-
By direct spread from the sinuses — through the bone between the sinuses and the brain.
These situations are very unusual and normally occur in patients whose immune defences are severely damaged.
📉 How common is it?
CNS (brain) aspergillosis makes up only a small fraction of all cases worldwide.
Even in high-risk hospital patients, it affects fewer than 1 in 10 people with invasive aspergillosis.
In people with allergic or chronic forms like ABPA or CPA, it’s almost unheard of.
❤️ What this means for you
If you have ABPA or CPA, the fungus in your lungs is not invading tissue in the same way.
It causes inflammation, allergy, or slow-growing cavities, but not deep invasion into blood vessels or brain tissue.
So, the risk of it spreading to the brain is extremely low.
Keep up with your usual care, medications, and check-ups — these control the lung disease and help prevent complications.
⚠️ When to seek medical advice
Contact your doctor urgently if you ever notice:
-
New or severe headaches
-
Changes in vision
-
Seizures or sudden weakness
-
Confusion or loss of balance
These symptoms are not common, but they’re always worth checking.
✅ Bottom line
The media headline is partly true — aspergillosis can reach the brain, but this happens almost only in people who are very immunocompromised.
For patients with ABPA or CPA, it is extremely rare and not something to fear day-to-day.
Share this post
Latest News posts
Understanding Risk from Aspergillosis — and What’s Improving
November 10, 2025
Understanding Risk: How Common Is “Rare”?
November 10, 2025
Aspergillosis & Asthma: When Risks Peak Through the Year
November 10, 2025
🏗️ Damp, Dust and Indoor Air Quality
November 10, 2025
🫁 Understanding Chronic Cough in Aspergillosis
October 30, 2025
💼 Aspergillosis, Scent Sensitivity, and the Workplace
October 30, 2025
🩺 Article 1: Managing Side Effects of Aspergillosis Treatments
October 30, 2025
⚠️ Omeprazole and PPIs: What’s Behind the Recent Warning?
October 30, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
